COMPOSITION FOR SUBCUTANEOUS ADMINISTRATION CONTAINING ANTI-HER2 ANTIBODY

摘要

The invention relates to the highly concentrated stable liquid pharmaceutical composition of anti-HER2 antibody contains anti-HER2 antibody selected from the group comprising Trastuzumab, Pertuzumab and T-DM1 at a concentration of 120 ± 18 µg/mL; the buffering agent for adjusting pH to 5.5 ± 2.0 at a concentration within 1-; the stabilizer or the mixture of stabilizers at a concentration within 1-; and non-ionogenic surface-active substance at a concentration within 0.01-0.08 %.